Inventor
HEINELT UWE
DE45 patents
⚠️ This page may combine multiple inventors who share the name “HEINELT UWE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA GMBH
11 patentsUS6911453B2Jun 28, 2005
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
AVENTIS PHARMA GMBH81 citations97
US6337344B1Jan 8, 2002
Indole derivatives as inhibitors or factor Xa
AVENTIS PHARMA GMBH81 citations97
US6399824B1Jun 4, 2002
Substituted cinnamic, acid guanidides, process for their preparation, their use as a medicament, and medicament comprising them
AVENTIS PHARMA GMBH64 citations96
US6737423B2May 18, 2004
Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
AVENTIS PHARMA GMBH38 citations92
US6703405B2Mar 9, 2004
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
AVENTIS PHARMA GMBH47 citations92
US6395737B1May 28, 2002
Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them
AVENTIS PHARMA GMBH57 citations92
US6500803B1Dec 31, 2002
Factor VIIa inhibitors
AVENTIS PHARMA GMBH14 citations84
US6825231B2Nov 30, 2004
Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
AVENTIS PHARMA GMBH8 citations74
US6958357B2Oct 25, 2005
Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
AVENTIS PHARMA GMBH6 citations73
US6686384B2Feb 3, 2004
Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them
AVENTIS PHARMA GMBH12 citations73
US6759420B1Jul 6, 2004
Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
AVENTIS PHARMA GMBH1 citations51
SANOFI AVENTIS DEUTSCHLAND
9 patentsUS7241775B2Jul 10, 2007
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
SANOFI AVENTIS DEUTSCHLAND65 citations98
US7049333B2May 23, 2006
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND14 citations92
US7790742B2Sep 7, 2010
Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions thereof, methods for their preparation and therapeutic use
SANOFI AVENTIS DEUTSCHLAND22 citations91
US7442717B2Oct 28, 2008
Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
SANOFI AVENTIS DEUTSCHLAND4 citations63
US7317033B2Jan 8, 2008
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND2 citations62
US7763643B2Jul 27, 2010
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7488746B2Feb 10, 2009
Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7179830B2Feb 20, 2007
Substituted thienoimidazoles useful for disease treatment and prevention
SANOFI AVENTIS DEUTSCHLAND1 citations51
US7179829B2Feb 20, 2007
Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them
SANOFI AVENTIS DEUTSCHLAND0 citations42
HEINELT UWE
8 patentsUS9079906B2Jul 14, 2015
Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8853206B2Oct 7, 2014
Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8198272B2Jun 12, 2012
Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8076336B2Dec 13, 2011
Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE1 citations51
US8067614B2Nov 29, 2011
N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them
HEINELT UWE1 citations47
US8653259B2Feb 18, 2014
Process for synthesizing heterocyclic compounds
HEINELT UWE0 citations41
US8598177B2Dec 3, 2013
Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations40
US8466169B2Jun 18, 2013
SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations40
SANOFI SA
6 patentsUS11130755B2Sep 28, 2021
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA2 citations72
US12275733B2Apr 15, 2025
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA0 citations62
US11827633B2Nov 28, 2023
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA1 citations62
US8871798B2Oct 28, 2014
Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
SANOFI SA3 citations59
US9550788B2Jan 24, 2017
Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
SANOFI SA0 citations50
US8791133B2Jul 29, 2014
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
SANOFI SA0 citations38
UCB BIOPHARMA SPRL
3 patentsUS10087179B2Oct 2, 2018
Fused tricyclic imidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations81
US9932343B2Apr 3, 2018
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL10 citations81
US10472362B2Nov 12, 2019
Fused tricyclic imidazo pyrazines as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations62
HOECHST AG
2 patentsUS5965555AOct 12, 1999
Xanthine compounds having terminally animated alkynol side chains
HOECHST AG81 citations95
US6214992B1Apr 10, 2001
Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
HOECHST AG10 citations72
SANOFI AVENTIS
2 patentsLANG HANS-JOCHEN
2 patentsUS8124621B2Feb 28, 2012
Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them
LANG HANS-JOCHEN0 citations38
US8106204B2Jan 31, 2012
Substituted 2-amino-4-phenyldihydroquinolines, processes for their preparation, pharmaceutical compositions and methods for their use
LANG HANS-JOCHEN0 citations38